epigallocatechin gallate has been researched along with Allergic Encephalomyelitis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, F; Chen, G; Guo, X; Guo, Z; Jin, S; Lei, Y; Liu, S; Niu, X; Wang, Z; Xi, Y; Zhao, H; Zhu, D | 1 |
| Bellmann-Strobl, J; Bros, H; Chanvillard, C; Fiebiger, S; Hamann, I; Hertwig, L; Infante-Duarte, C; Janssen, A; Millward, JM; Paul, F; Romero-Suarez, S | 1 |
| Bardua, M; Behrens, J; Bellmann-Strobl, J; Bock, M; Boschmann, M; Bremer, D; Füchtemeier, M; Gerhard, J; Hauser, AE; Herz, J; Infante-Duarte, C; Lindquist, R; Mähler, A; Millward, JM; Mossakowski, AA; Mothes, R; Niesner, R; Pache, FC; Paul, F; Pohlan, J; Pollok, K; Priller, J; Radbruch, H; Radbruch, M; Rinnenthal, JL; Viohl, L | 1 |
| Ângela Mazıero Volpato, C; Antônıo Bottıno, M; Francısco Cesar, P; Wu, D | 1 |
| Aktas, O; Hentschel, N; Herges, K; Infante-Duarte, C; Millward, JM; Zipp, F | 1 |
| Meydani, SN; Ren, Z; Wang, J; Wu, D; Xiao, S; Xu, Y | 1 |
| Hu, X; Nie, H; Sun, Q; Wang, Y; Zhang, D; Zhang, S; Zhang, X; Zheng, Y | 1 |
| Aktas, O; Brocke, S; Infante-Duarte, C; Kloetzel, PM; Lauster, R; Prozorovski, T; Savaskan, NE; Smorodchenko, A; Zipp, F | 1 |
| Aktas, O; Waiczies, S; Zipp, F | 1 |
2 review(s) available for epigallocatechin gallate and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Topics: Animals; Catechin; Ceramics; Color; Crowns; Cytokines; Dental Porcelain; Dental Veneers; Encephalomyelitis, Autoimmune, Experimental; Humans; Lymphocyte Activation; Materials Testing; T-Lymphocytes; Tea; Time Factors; Zirconium | 2016 |
Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets.
Topics: Acyl Coenzyme A; Animals; Catechin; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Humans; Multiple Sclerosis; Nerve Degeneration; Neuroprotective Agents; T-Lymphocytes; TNF-Related Apoptosis-Inducing Ligand | 2007 |
1 trial(s) available for epigallocatechin gallate and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Tracking CNS and systemic sources of oxidative stress during the course of chronic neuroinflammation.
Topics: Animals; Antioxidants; Astrocytes; Calcium; Catechin; CD11b Antigen; Chronic Disease; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Glatiramer Acetate; Humans; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Fluorescence; Multiple Sclerosis; NADPH Oxidases; Neurons; Oxidative Stress | 2015 |
6 other study(ies) available for epigallocatechin gallate and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Epigallocatechin-3 gallate regulates macrophage subtypes and immunometabolism to ameliorate experimental autoimmune encephalomyelitis.
Topics: Animals; Catechin; Cell Differentiation; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Glycolysis; Humans; Macrophages; Male; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Neuroprotective Agents; NF-kappa B; Signal Transduction; Tea; Th1 Cells; Th2 Cells | 2021 |
Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1.
Topics: Animals; Axons; Catechin; Chronic Disease; Down-Regulation; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression Regulation, Enzymologic; Glatiramer Acetate; Heme Oxygenase-1; Membrane Proteins; Mice; Myelin Sheath; Oxidation-Reduction | 2015 |
Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation.
Topics: Animals; Axons; Catechin; Cell Count; Cell Death; Central Nervous System; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Female; Glatiramer Acetate; Inflammation; Mice; Neuroprotective Agents; Peptides | 2011 |
Epigallocatechin-3-gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4+ T-cell subsets.
Topics: Animals; Catechin; CD4-Positive T-Lymphocytes; Cell Proliferation; Cytokines; Demyelinating Diseases; Dietary Supplements; Down-Regulation; Encephalomyelitis, Autoimmune, Experimental; Female; Mice; Mice, Inbred C57BL; Monocytes; Multiple Sclerosis; Myelin Proteins; Myelin-Oligodendrocyte Glycoprotein; Neuritis; Neuroprotective Agents; Nuclear Receptor Subfamily 1, Group F, Member 3; Random Allocation; T-Box Domain Proteins; T-Lymphocyte Subsets | 2012 |
Novel immunoregulatory properties of EGCG on reducing inflammation in EAE.
Topics: Animals; Antigen-Presenting Cells; Catechin; CD4-Positive T-Lymphocytes; Cell Differentiation; Encephalomyelitis, Autoimmune, Experimental; Male; Mice; Mice, Inbred C57BL; Multiple Sclerosis; STAT Transcription Factors; Th17 Cells | 2013 |
Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis.
Topics: Administration, Oral; Animals; Catechin; Cell Death; Cell Line; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Down-Regulation; Encephalomyelitis, Autoimmune, Experimental; Female; Growth Inhibitors; Humans; I-kappa B Proteins; Immunity, Cellular; Jurkat Cells; Mice; Neurons; Neuroprotective Agents; NF-kappa B; NF-KappaB Inhibitor alpha; Proto-Oncogene Proteins; Reactive Oxygen Species; T-Lymphocytes; Tea; Up-Regulation | 2004 |